Digital vs conventional glycemic monitoring in rare endocrine cancers: comparison of effectiveness during chemotherapy
We demonstrated a previously underestimated frequency of hyperglycemia and SIH in patients undergoing chemotherapy by using rtCGM. The use of rtCGM enabled more detailed recognition of dysglycemia and may improve glucose metabolism during and after chemotherapy regimens.
Authors
- Lukas van Baal (ORCID: https://orcid.org/0000-0001-7814-1223)
- Lars C. Moeller (ORCID: https://orcid.org/0000-0002-9330-9036)
- Jasna Pavlović
- Dagmar Führer (ORCID: https://orcid.org/0000-0003-0357-4192)
- Nicole Unger (ORCID: https://orcid.org/0000-0002-5161-8711)
- Annie Mathew (ORCID: https://orcid.org/0000-0003-3233-5609)
- Harald Lahner
Institutions
- European Neuroendocrine Tumor Society (DE)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1530/ec-25-0709
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft